Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Papillomavirus Infections 2Uterine Cervical Neoplasms 1

Interventions

pembrolizumab 14Cisplatin 13Specimen Handling 11Magnetic Resonance Spectroscopy 7Brachytherapy 7Bevacizumab 7Radiotherapy 6atezolizumab 5Platinum 5Paclitaxel 5Nivolumab 5Human Papillomavirus DNA Tests 5Gemcitabine 5Colposcopy 5Carboplatin 5Blood Specimen Collection 5Radiation 4Fulvestrant 4lenvatinib 3Surveys and Questionnaires 3Radiation Dose Hypofractionation 3Drug Therapy 3Biopsy 31,2-diaminocyclohexaneplatinum II citrate 3zimberelimab 2tisotumab vedotin 2spartalizumab 2palbociclib 2camrelizumab 2X-Rays 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × Papillomavirus Vaccines × 90 days × Clear all
NCT04185389 2026-04-28

HPV FOCAL

University of British Columbia

Completed
1,710 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡